Bruker CorporationBRKRNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-25.0%
5Y CAGR-11.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-25.0%/yr
vs +3.4%/yr prior
5Y CAGR
-11.7%/yr
Recent deceleration
Acceleration
-28.4pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM8.65%-33.6%
202413.03%-42.8%
202322.79%+11.2%
202220.50%-0.3%
202120.56%+27.5%
202016.13%-10.1%
201917.95%+0.0%
201817.94%+5.8%
201716.96%+4.3%
201616.27%-